Trial site
University of Washington - Seattle Cancer Care Alliance
- 9running trials
- 10closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer3 trials
- Ovarian cancer3 trials
- Childhood cancers2 trials
- Follicular lymphoma2 trials
- Prostate cancer2 trials
- Cervical cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Glioblastoma1 trial
- Head and neck cancer1 trial
- Hodgkin lymphoma1 trial
- Liver and biliary tract cancer1 trial
- and 4 more
- Phase
- Phase 29 trials
- Phase 1/24 trials
- Phase 34 trials
- Phase 2/31 trial
- Status
- Completed9 trials
- Active, not recruiting7 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Daiichi Sankyo3 trials
- Incyte Corporation3 trials
- Bristol-Myers Squibb2 trials
- Hoffmann-La Roche2 trials
- Enterome1 trial
- and 8 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Terminated
RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC
Completed
Completed
A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies
Completed
Completed
Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian
Completed
Completed
Completed
PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026